Over-the-Counter (OTC) Analgesics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region, and Competition 2018-2028

  • Industry : Healthcare
  • Pages : NA
  • Published Date : NA
Customization Enquiry

Buy Now

Summary

Report Description

 

Forecast Period

2024-2028

Market Size (2022)

USD 19.07 Billion

CAGR (2023-2028)

8.00%

Fastest Growing Segment

Online Pharmacies

Largest Market

North America

 

Market Overview

Global Over-the-Counter (OTC) Analgesics Market has valued at USD 19.07 Billion in 2022 and is anticipated to project robust growth in the forecast period with a CAGR of 8.00% through 2028. Cell-penetrating peptides (CPPs) are a class of peptides that were identified as being capable of transporting the molecules they are linked with across cellular membranes. Therefore, a promising approach for enhancing the permeability of therapeutic proteins and peptides across cellular membranes is by attaching them to a CPP. Cell-penetrating peptides (CPPs) have garnered substantial attention in recent years due to their remarkable potential in delivering various therapeutic agents across cellular membranes. The global cell-penetrating peptides market is experiencing significant growth, driven by several key factors that are shaping the landscape of this industry.

Key Market Drivers

Rising Aging Population and Chronic Conditions

The global over-the-counter (OTC) analgesics market is influenced by a variety of factors, and two significant ones are the aging population and the prevalence of chronic conditions. Older individuals often require pain relief on a regular basis to manage chronic conditions. This leads to a sustained demand for OTC analgesics. Many older individuals may prefer OTC analgesics due to their convenience and accessibility, as well as a desire to avoid more potent prescription medications. Chronic conditions typically lead to ongoing pain and discomfort that individuals seek to manage on a regular basis. This results in a consistent and sustained demand for pain relief medications, including OTC analgesics. Consumers with chronic conditions often require pain relief that is convenient and accessible without the need for a prescription. Chronic conditions are not limited to a specific age group. They affect individuals of various age ranges, from young adults to the elderly. As a result, the market for OTC analgesics targeting chronic pain is broad and diverse. Individuals with chronic conditions often prefer OTC analgesics due to their convenience and ease of accessibility. These medications can be purchased without the need for a doctor's prescription, making them a convenient choice for managing day-to-day pain associated with chronic conditions. As awareness and education about chronic conditions increase, more individuals become informed about available pain relief options. This awareness can lead to greater demand for OTC analgesics, as people seek to proactively manage their pain. According to the report published by the National High School Sports-Related Injury Surveillance Study in August 2022, 4,998 injuries were reported in the academic year 2021/22 in the United States, with an injury incidence of 2.02 injuries per 1,000 athletes exposures in 20 sports.

Growing Consumer Awareness and Self-Care Trends

Growing consumer awareness and self-care trends have a substantial impact on the growth of the global Over-the-Counter (OTC) analgesics market. These trends reflect a shift in consumer preferences and behaviors, influencing how individuals approach pain relief and overall well-being. As consumers become more informed about health and wellness, they seek to understand their options for managing minor health issues like pain. The availability of information through the internet and other sources empowers consumers to make educated decisions about their health, including selecting appropriate OTC analgesics for pain relief. Self-care trends encourage individuals to take responsibility for their health and well-being. Consumers are increasingly inclined to manage mild to moderate pain on their own before seeking professional medical help. OTC analgesics provide a convenient and accessible way for consumers to address pain without the need for a doctor's prescription. OTC analgesics are widely available in pharmacies, supermarkets, convenience stores, and online platforms. Consumers are drawn to these easily accessible options, allowing them to address pain promptly and without the hassle of visiting a healthcare provider. Modern lifestyles often involve busy schedules and increased stress, which can contribute to occasional pain and discomfort. OTC analgesics provide a quick and effective solution for managing these minor issues, helping individuals maintain their productivity and quality of life. As consumer awareness grows, manufacturers can focus on targeted marketing campaigns to educate consumers about the benefits and appropriate usage of their OTC analgesic products. Additionally, they can invest in research and development to create innovative products that cater to specific pain relief needs.

Rising Healthcare Costs

Rising healthcare costs have a significant influence on the growth of the global Over-the-Counter (OTC) analgesics market. As healthcare expenses continue to increase, individuals and healthcare systems are seeking more cost-effective solutions for managing minor health issues, such as pain relief. OTC analgesics offer a more affordable alternative to prescription medications for managing mild to moderate pain. As healthcare costs rise, consumers may be more inclined to opt for OTC options that provide effective relief without the added expense of doctor visits, prescriptions, and co-pays. Individuals are more likely to turn to OTC analgesics for pain relief in non-emergency situations when immediate medical attention is not necessary. Rising healthcare costs may encourage people to conserve resources and avoid unnecessary trips to medical facilities for minor health concerns. Some individuals might use OTC analgesics to prevent the escalation of minor pain into more serious health issues that would require costly medical interventions. By addressing pain early, consumers can potentially avoid higher healthcare costs associated with untreated conditions. Consumers may choose OTC analgesics as a cost-effective option, especially if their insurance plans have high deductibles or limited coverage for non-prescription medications.

Product Innovation and Marketing

Product innovation and marketing play crucial roles in driving the growth of the global Over-the-Counter (OTC) analgesics market. These factors influence consumer perceptions, preferences, and purchasing decisions, ultimately shaping the market's expansion. Manufacturers can develop innovative formulations and delivery methods that enhance the effectiveness, speed, or convenience of pain relief. This could include fast-dissolving tablets, patches, gels, and sprays, catering to different consumer preferences and needs. Developing OTC analgesics tailored to specific types of pain, such as migraine-specific formulas or arthritis-targeted products, can attract consumers looking for solutions that address their unique pain management needs. Some consumers prefer natural or herbal alternatives. Manufacturers can innovate by incorporating botanical ingredients known for their analgesic properties into OTC products, providing more options for health-conscious consumers. Developing OTC analgesics with extended-release capabilities can provide longer-lasting pain relief and reduce the need for frequent dosing.


Download Free Sample Report

Key Market Challenges

Regulatory Scrutiny and Safety Concerns

Regulatory scrutiny and safety concerns can indeed hinder the growth of the global Over-the-Counter (OTC) analgesics market. While OTC analgesics offer accessible and convenient pain relief options, regulatory agencies and safety considerations play a significant role in shaping the market environment. Regulatory agencies enforce strict safety standards for OTC medications to ensure consumer safety. Manufacturers must adhere to guidelines related to active ingredients, dosages, and potential interactions with other medications. If a particular ingredient or formulation is found to have safety risks, regulatory authorities can restrict or even remove it from the market. This can limit product choices for consumers and impact market growth. Reports of adverse events, unexpected side effects, or product recalls can erode consumer trust in OTC analgesic products. Publicized safety concerns can lead to decreased sales, lower consumer confidence, and heightened regulatory scrutiny, all of which can hinder market growth. Certain OTC analgesics may have age restrictions or warnings for specific populations, such as children, pregnant women, or individuals with certain medical conditions. These restrictions can limit the target audience and reduce the overall market size. OTC analgesics often require clear and comprehensive warning labels to inform consumers about proper usage, potential side effects, and contraindications. If consumers are hesitant to use products due to concerns raised by warning labels, it can impact market growth.

Patent Expirations and Generic Competition

Patent expirations and generic competition can indeed hinder the growth of the global Over-the-Counter (OTC) analgesics market. When a medication's patent expires, it allows generic manufacturers to produce and market equivalent versions of the drug. Once a patent expires and generic versions become available, the market experiences increased competition. Generic drugs are typically priced lower than their brand-name counterparts. This price competition can lead to a reduction in the overall market value, as consumers switch to more affordable options. Generic competition can lead to a loss of market share for the original brand-name OTC analgesics. Consumers often opt for the less expensive generic versions, which can impact the revenue and growth potential of the original product. Generic drugs are generally sold at lower prices, resulting in reduced profit margins for both brand-name manufacturers and retailers. This can hinder the financial growth and incentive for innovation within the OTC analgesics market. Brand-name manufacturers may reduce their marketing and promotional efforts for a product nearing its patent expiration if they anticipate a significant loss of market share to generic alternatives. This can impact the visibility and growth potential of the product. The prospect of generic competition can discourage brand-name manufacturers from investing in research and development (R&D) to create innovative OTC analgesic products. This lack of innovation can hinder differentiation and growth in the market. Generic drugs are often perceived as equivalent to brand-name products in terms of efficacy and safety. As such, consumers may switch to generics without hesitation, reducing demand for the original OTC analgesic. Generic manufacturers must meet regulatory standards for bioequivalence to the original brand-name product. This ensures that the generic is comparable in terms of efficacy and safety. However, meeting these requirements can be time-consuming and costly, potentially impacting the availability of generic versions.

Key Market Trends

Personalized Pain Relief Solutions

Personalized pain relief solutions have the potential to significantly influence the growth of the global Over-the-Counter (OTC) analgesics market. Personalization involves tailoring products to individual needs and preferences, and it aligns well with the evolving trends in healthcare and consumer demands. Personalized solutions allow OTC analgesics to be formulated for specific types of pain, such as migraines, menstrual pain, joint pain, or muscle soreness. This customization addresses the diverse needs of consumers and can lead to increased demand for these specialized products. Offering personalized pain relief options engages consumers on a more personal level. When individuals feel that a product is designed specifically for their needs, they are more likely to choose and remain loyal to that product, driving market growth. Manufacturers can expand their product lines to offer a wider range of personalized options. This diversity can attract different consumer segments, increasing market penetration and overall sales. Manufacturers that invest in personalized pain relief solutions can differentiate themselves from competitors and drive innovation in the market. This innovation can lead to increased interest from consumers and growth opportunities. When consumers find a personalized pain relief solution that works for them, they are more likely to become repeat customers. This loyalty contributes to steady sales and market growth over time.

Regulatory Shifts and Ingredient Scrutiny

Regulatory shifts and ingredient scrutiny have a significant impact on the growth of the global Over-the-Counter (OTC) analgesics market. Changes in regulations and increased scrutiny of the ingredients used in OTC analgesic products can influence product availability, formulation, and consumer perception. regulatory shifts often lead to changes in labeling requirements. Manufacturers may need to update their packaging to include additional warnings, dosing instructions, or information about potential interactions with other medications. This can affect product packaging design and consumer comprehension. Stringent regulatory requirements can serve as barriers to entry for new players in the OTC analgesics market. Newcomers must navigate complex regulations and safety assessments, which can slow down the introduction of innovative products and hinder market growth. International regulatory shifts can lead to standardization of ingredient lists, safety standards, and labeling requirements across different countries. While this can improve consistency, it can also limit regional variations and hinder the growth of niche products. Regulatory shifts often require manufacturers to conduct more extensive testing and provide additional documentation to prove the safety and efficacy of their products. This can increase costs and delay product launches, impacting market growth. Ingredient scrutiny can affect relationships with suppliers who provide the ingredients for OTC analgesic products. Manufacturers may need to find alternative sources if certain ingredients are restricted, which can impact supply chains and product consistency.

Segmental Insights

Drug Type Insights

Based on the Drug Type, the Nonsteroidal Anti-inflammatory Drugs (NSAIDs) segment is anticipated to witness substantial market growth throughout the forecast period. This growth can be attributed to multiple factors, such as NSAIDs are versatile pain relievers used for a variety of conditions, including headaches, muscle aches, menstrual pain, arthritis, and more. This versatility increases their appeal to consumers seeking OTC pain relief options. NSAIDs are effective in providing strong pain relief, making them a popular choice for individuals experiencing moderate to severe pain. This effectiveness contributes to consumer trust and loyalty in OTC NSAID products. Many individuals seek OTC pain relief options that also target inflammation. NSAIDs offer anti-inflammatory properties that make them suitable for conditions characterized by inflammation, such as arthritis and sports injuries. Manufacturers often market specific NSAID products for certain types of pain, such as menstrual pain or back pain. This targeted marketing approach can attract consumers seeking tailored solutions for their pain relief needs.

End Use Insights

Based on the end-use segment, the Retail Pharmacies segment has been the dominant force in the market. Retail pharmacies offer a convenient and easily accessible way for consumers to purchase OTC analgesics. The widespread presence of retail pharmacy chains in urban and suburban areas ensures that consumers can quickly obtain pain relief products. Retail pharmacies stock a diverse range of OTC analgesic products, providing consumers with choices that cater to their preferences, needs, and pain types. Pharmacists and pharmacy staff at retail pharmacies can offer guidance and recommendations to consumers seeking OTC analgesics. Their expertise helps consumers make informed decisions about which products to choose based on their symptoms and medical history. Retail pharmacies often include educational materials near OTC analgesic displays. These materials provide information about pain relief, dosages, potential side effects, and proper usage, contributing to consumer knowledge. Patients who receive recommendations for OTC analgesics from healthcare professionals, hospitals, or clinics can easily find and purchase those products at retail pharmacies, ensuring continuity of care. Many retail pharmacies also have online platforms that allow consumers to purchase OTC analgesics online, expanding the reach and accessibility of these products.


Download Free Sample Report

Regional Insights

North America, specifically the Over-the-Counter (OTC) Analgesics Market, dominated the market in 2022, primarily due to North America, particularly the United States, has a large population and strong purchasing power. This population size and disposable income contribute to higher demand for OTC analgesics and drive market growth. Chronic pain conditions, such as arthritis, back pain, and migraines, are common in North America. The high prevalence of these conditions leads to sustained demand for OTC analgesics. Consumers in North America are often well-informed about health and wellness topics. This awareness drives demand for OTC analgesics as individuals actively seek solutions for pain relief and overall well-being. There is a growing trend in North America towards self-care and proactive health management. Consumers prefer managing minor health issues on their own, which aligns with the accessibility and convenience of OTC analgesics. North America has a well-developed retail pharmacy network and e-commerce infrastructure. This makes OTC analgesics easily accessible through various channels, contributing to market growth. The presence of major pharmaceutical companies and healthcare institutions in North America drives research, development, and innovation in the OTC analgesics sector.

Recent Developments

  • In January 2023: Medterra launched its newest product, Natural Pain Relief capsules. Medterra Natural Pain Relief is a clinically proven, plant-based pain reliever formulated to alleviate muscle pain, joint stiffness, and inflammation without the negative side effects often associated with over-the-counter (OTC) options.
  • In January 2023: Ratiopharm, a German pharmaceutical company, launched an over-the-counter combination pain reliever named Synofen, which contains 200 mg ibuprofen and 500 mg paracetamol.
  • In March 2023, US FDA announced the approval of Narcan, and to be made available OTC without prescription. Narcan is used to reverse the effects caused by an overdose of opioids rapidly and is deemed the standard treatment for such emergencies.

Key Market Players

  • Bayer AG.
  • Boehringer Ingelheim International GmbH
  • Johnson & Johnson Services Inc
  • GSK plc
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company Limited
  • AstraZeneca PLC
  • Merck & Co Inc.

 By Drug Type

By Distribution Channel

By Region
  • Acetaminophen
  • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
  • Salicylates
  • Other Analgesics
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies 
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa
Report Scope:

In this report, the Global Over-the-Counter (OTC) Analgesics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Over-the-Counter (OTC) Analgesics Market, By Drug Type:

o   Acetaminophen

o   Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

o   Salicylates

o   Other Analgesics

  • Over-the-Counter (OTC) Analgesics Market, By Distribution Channel:

o   Hospital Pharmacies

o   Retail Pharmacies

o   Online Pharmacies

  • Over-the-Counter (OTC) Analgesics Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

§  Kuwait

§  Turkey

§  Egypt

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Over-the-Counter (OTC) Analgesics Market.

Available Customizations:

Global Over-the-Counter (OTC) Analgesics market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Over-the-Counter (OTC) Analgesics Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.     Markets Covered

1.2.2.     Years Considered for Study

1.2.3.     Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Global Over-the-Counter (OTC) Analgesics Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value

5.2.  Market Share & Forecast

5.2.1.     By Drug Type (Acetaminophen, Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Salicylates and Other Analgesics)

5.2.2.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

5.2.3.     By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)

5.2.4.     By Company (2022)

5.3.  Market Map

5.3.1 By Drug Type

5.3.2 By Distribution Channel

5.3.3 By Region

6.    North America Over-the-Counter (OTC) Analgesics Market Outlook

6.1.  Market Size & Forecast          

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Drug Type

6.2.2.     By Distribution Channel

6.2.3.     By Country

6.3.  North America: Country Analysis

6.3.1.     United States Over-the-Counter (OTC) Analgesics Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Drug Type

6.3.1.2.2.             By Distribution Channel

6.3.2.     Canada Over-the-Counter (OTC) Analgesics Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Drug Type

6.3.2.2.2.             By Distribution Channel

6.3.3.     Mexico Over-the-Counter (OTC) Analgesics Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Drug Type

6.3.3.2.2.             By Distribution Channel

7.    Europe Over-the-Counter (OTC) Analgesics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Drug Type

7.2.2.     By Distribution Channel

7.2.3.     By Country

7.3.  Europe: Country Analysis

7.3.1.     France Over-the-Counter (OTC) Analgesics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Drug Type

7.3.1.2.2.             By Distribution Channel

7.3.2.     Germany Over-the-Counter (OTC) Analgesics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Drug Type

7.3.2.2.2.             By Distribution Channel

7.3.3.     United Kingdom Over-the-Counter (OTC) Analgesics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Drug Type

7.3.3.2.2.             By Distribution Channel

7.3.4.     Italy Over-the-Counter (OTC) Analgesics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Drug Type

7.3.4.2.2.             By Distribution Channel

7.3.5.     Spain Over-the-Counter (OTC) Analgesics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Drug Type

7.3.5.2.2.             By Distribution Channel

8.    Asia-Pacific Over-the-Counter (OTC) Analgesics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Drug Type

8.2.2.     By Distribution Channel

8.2.3.     By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.     China Over-the-Counter (OTC) Analgesics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Drug Type

8.3.1.2.2.             By Distribution Channel

8.3.2.     India Over-the-Counter (OTC) Analgesics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Drug Type

8.3.2.2.2.             By Distribution Channel

8.3.3.     Japan Over-the-Counter (OTC) Analgesics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Drug Type

8.3.3.2.2.             By Distribution Channel

8.3.4.     South Korea Over-the-Counter (OTC) Analgesics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Drug Type

8.3.4.2.2.             By Distribution Channel

8.3.5.     Australia Over-the-Counter (OTC) Analgesics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Drug Type

8.3.5.2.2.             By Distribution Channel

9.    South America Over-the-Counter (OTC) Analgesics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Drug Type

9.2.2.     By Distribution Channel

9.2.3.     By Country

9.3.  South America: Country Analysis

9.3.1.     Brazil Over-the-Counter (OTC) Analgesics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Drug Type

9.3.1.2.2.             By Distribution Channel

9.3.2.     Argentina Over-the-Counter (OTC) Analgesics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Drug Type

9.3.2.2.2.             By Distribution Channel

9.3.3.     Colombia Over-the-Counter (OTC) Analgesics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Drug Type

9.3.3.2.2.             By Distribution Channel

10.  Middle East and Africa Over-the-Counter (OTC) Analgesics Market Outlook

10.1.              Market Size & Forecast

10.1.1.   By Value

10.2.              Market Share & Forecast

10.2.1.   By Drug Type

10.2.2.   By Distribution Channel

10.2.3.   By Country

10.3.              MEA: Country Analysis

10.3.1.   South Africa Over-the-Counter (OTC) Analgesics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Drug Type

10.3.1.2.2.           By Distribution Channel

10.3.2.   Saudi Arabia Over-the-Counter (OTC) Analgesics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Drug Type

10.3.2.2.2.           By Distribution Channel

10.3.3.   UAE Over-the-Counter (OTC) Analgesics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Drug Type

10.3.3.2.2.           By Distribution Channel

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

12.1.              Recent Development

12.2.              Mergers & Acquisitions

12.3.              Product Launches

13.  Global Over-the-Counter (OTC) Analgesics Market: SWOT Analysis

14.  Porter’s Five Forces Analysis

14.1.              Competition in the Industry

14.2.              Potential of New Entrants

14.3.              Power of Suppliers

14.4.              Power of Customers

14.5.              Threat of Substitute Products

15.  Competitive Landscape

15.1.              Business Overview

15.2.              Product Offerings

15.3.              Recent Developments

15.4.              Financials (As Reported)

15.5.              Key Personnel

15.6.              SWOT Analysis

15.6.1    Bayer AG.

15.6.2    Boehringer Ingelheim International GmbH

15.6.3    Johnson & Johnson Services Inc

15.6.4    GSK plc

15.6.5    Pfizer Inc.

15.6.6    Sanofi SA

15.6.7    Sun Pharmaceutical Industries Ltd.

15.6.8    Takeda Pharmaceutical Company Limited

15.6.9    AstraZeneca Plc

15.6.10  Merck & Co Inc.

16. Strategic Recommendations

Figures and Tables

Frequently asked questions

down-arrow

The market size of the Global Over-the-Counter (OTC) Analgesics Market was estimated to be USD 19.07 Billion in 2022.

down-arrow

The retail pharmacies segment demonstrated significant dominance in 2022, primarily driven rising number of retail pharmacies providing over the counter (OTC) drugs. Due to the growing number of retail pharmacies offering over the counter medications and growing patient preference for these items, the drug stores and retail pharmacies category is expected to account for the greatest market share over the projection period.

down-arrow

North America emerged as the dominant market in 2022, capturing a significant revenue share. North America region’s supremacy can be linked to consumer’s growing preference for over the counter (OTC) drugs over prescription drugs. The growth of over the counter drugs market in North America region is being driven by the growing consumption of over the counter drugs.

down-arrow

Growing approvals for over the counter drugs, increased patent expirations of many pharmaceuticals, resulting in their utilization as over the counter drugs are the major drivers for the Global Over-the-Counter (OTC) Analgesics Market.

Related Reports

profile

Sakshi Bajaal

Business Consultant
Press Release

Global Over-the-Counter (OTC) Analgesics Market to Grow with a CAGR of 8.00% through 2028

Oct, 2023

Increasing demand for topical analgesics is expected to drive the Global Over-the-Counter (OTC) Analgesics Market growth in the forecast period, 2024-2028.

Why Choose Us